To provide for increased research and initiatives related to bleeding disorders in underserved populations, and for other purposes.

Referred to the House Committee on Energy and Commerce.

2026-05-13

The legislation would direct federal funding toward research and treatment programs focused on bleeding disorders like hemophilia in communities that currently lack adequate medical resources and care. It aims to improve diagnosis, treatment access, and health outcomes for patients in underserved areas who may have limited access to specialists and expensive therapies. The bill would affect patients with bleeding disorders, healthcare providers in underserved regions, and medical research institutions working on these conditions.